搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
6 天
Pancreatic cancer patient survival doubled with high dose of common vitamin, study finds
Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in ...
7 小时
ABC13's Mark Spain battles Stage 4 pancreatic cancer after diagnosis
ABC13's Mark Spain faces a battle against Stage 4 pancreatic cancer, but he has an entire community behind him.
8 小时
Nanobiotix ADRs Jump on Completed Pancreatic Cancer Treatment Study
Nanobiotix's American depositary receipts climbed after the company completed the Phase 1 study of its pancreatic cancer treatment. The stock was up 18% at $3.55 in premarket trading. Shares had ...
3 天
Unscripted: Pancreatic cancer treatment
FOX 13's Allie Corey sat down with the chief of surgical oncology at TGH Institute and professor of surgery at USF Health as ...
8 天
Novocure Moves Pancreatic Cancer Treatment Forward With A 'First' Using TTFields
Novocure’s positive phase 3 results boost pancreatic cancer treatment prospects. Read why NVCR stock is worth watching with ...
Cure Today
6 天
Phase 3 Study for Advanced Pancreatic Cancer Meets Survival Goal
Patients with locally advanced pancreatic cancer demonstrated a two-month difference in survival with tumor-treating fields ...
health.economictimes.indiatimes
7 天
Novocure's pancreatic cancer treatment meets main goal in late-stage study
The therapy uses Tumor Treating Fields, or electric fields, to kill cancer cells while sparing most nearby healthy cells, ...
Too Old to Operate
8 小时
GemCap Improves OS in Pancreatic Cancer Compared to Gemcitabine
Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial,” published in the December 2024 issue of Oncology by ...
manilatimes
23 小时
NANOBIOTIX Announces Completion of Phase 1 Study of NBTXR3 (JNJ-1900) in Pancreatic Cancer
Investigators concluded that the encouraging oncologic outcomes coupled with a favorable safety profile warrant further ...
The Brighterside of News on MSN
3 天
Breakthrough immunotherapy drug revolutionizes pancreatic cancer treatment
Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers, with a survival rate of just 11%. A primary culprit ...
5 天
Personalized medicine could help doctors detect pancreatic cancer earlier, Fox Chase Cancer ...
There's no routine screening test for pancreatic cancer, and symptoms can be mistaken for common illnesses.
5 天
NovoCure: PANOVA-3 Data Suggests A Potential Game-Changer For Pancreatic Cancer
NovoCure's TTFields therapy, combined with standard chemotherapy, improves overall survival in advanced pancreatic cancer.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈